Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Nogo-A-deficient Transgenic Rats Show Deficits in Higher Cognitive Functions, Decreased Anxiety, and Altered Circadian Activity Patterns.

Petrasek T, Prokopova I, Sladek M, Weissova K, Vojtechova I, Bahnik S, Zemanova A, Schönig K, Berger S, Tews B, Bartsch D, Schwab ME, Sumova A, Stuchlik A.

Front Behav Neurosci. 2014 Mar 18;8:90. doi: 10.3389/fnbeh.2014.00090. eCollection 2014.

PMID:
24672453
[PubMed]
Free PMC Article
2.

Reduced expression of nogo-a leads to motivational deficits in rats.

Enkel T, Berger SM, Schönig K, Tews B, Bartsch D.

Front Behav Neurosci. 2014 Jan 22;8:10. doi: 10.3389/fnbeh.2014.00010. eCollection 2014.

PMID:
24478657
[PubMed]
Free PMC Article
3.

Nogo-A downregulation impairs place avoidance in the Carousel maze but not spatial memory in the Morris water maze.

Petrasek T, Prokopova I, Bahnik S, Schonig K, Berger S, Vales K, Tews B, Schwab ME, Bartsch D, Stuchlik A.

Neurobiol Learn Mem. 2014 Jan;107:42-9. doi: 10.1016/j.nlm.2013.10.015. Epub 2013 Nov 6.

PMID:
24211256
[PubMed - indexed for MEDLINE]
4.

N-Methyl-d-Aspartate Receptor - Nitric Oxide Synthase Pathway in the Cortex of Nogo-A-Deficient Rats in Relation to Brain Laterality and Schizophrenia.

Krištofiková Z, Vrajová M, Sírová J, Valeš K, Petrásek T, Schönig K, Tews B, Schwab M, Bartsch D, Stuchlík A, Rípová D.

Front Behav Neurosci. 2013 Aug 12;7:90. doi: 10.3389/fnbeh.2013.00090. eCollection 2013.

PMID:
23964213
[PubMed]
Free PMC Article
5.

Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function.

Tews B, Schönig K, Arzt ME, Clementi S, Rioult-Pedotti MS, Zemmar A, Berger SM, Schneider M, Enkel T, Weinmann O, Kasper H, Schwab ME, Bartsch D.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6583-8. doi: 10.1073/pnas.1217665110. Epub 2013 Apr 1.

PMID:
23576723
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.

Lee J, Ballikaya S, Schönig K, Ball CR, Glimm H, Kopitz J, Gebert J.

PLoS One. 2013;8(2):e57074. doi: 10.1371/journal.pone.0057074. Epub 2013 Feb 27.

PMID:
23468914
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schönig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, Müller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, Masliah E, Riess O.

Brain. 2013 Feb;136(Pt 2):412-32. doi: 10.1093/brain/aws358.

PMID:
23413261
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Tet-Transgenic Rodents: a comprehensive, up-to date database.

Schönig K, Freundlieb S, Gossen M.

Transgenic Res. 2013 Apr;22(2):251-4. doi: 10.1007/s11248-012-9660-9. Epub 2012 Nov 23.

PMID:
23180363
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Conditional gene expression systems in the transgenic rat brain.

Schönig K, Weber T, Frömmig A, Wendler L, Pesold B, Djandji D, Bujard H, Bartsch D.

BMC Biol. 2012 Sep 3;10:77. doi: 10.1186/1741-7007-10-77.

PMID:
22943311
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Srgap3⁻/⁻ mice present a neurodevelopmental disorder with schizophrenia-related intermediate phenotypes.

Waltereit R, Leimer U, von Bohlen Und Halbach O, Panke J, Hölter SM, Garrett L, Wittig K, Schneider M, Schmitt C, Calzada-Wack J, Neff F, Becker L, Prehn C, Kutscherjawy S, Endris V, Bacon C, Fuchs H, Gailus-Durner V, Berger S, Schönig K, Adamski J, Klopstock T, Esposito I, Wurst W, de Angelis MH, Rappold G, Wieland T, Bartsch D.

FASEB J. 2012 Nov;26(11):4418-28. doi: 10.1096/fj.11-202317. Epub 2012 Jul 20.

PMID:
22820399
[PubMed - indexed for MEDLINE]
Free Article
11.

Tetracycline inducible gene manipulation in serotonergic neurons.

Weber T, Renzland I, Baur M, Mönks S, Herrmann E, Huppert V, Nürnberg F, Schönig K, Bartsch D.

PLoS One. 2012;7(5):e38193. doi: 10.1371/journal.pone.0038193. Epub 2012 May 31.

PMID:
22693598
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Retrocochlear function of the peripheral deafness gene Cacna1d.

Satheesh SV, Kunert K, Rüttiger L, Zuccotti A, Schönig K, Friauf E, Knipper M, Bartsch D, Nothwang HG.

Hum Mol Genet. 2012 Sep 1;21(17):3896-909. doi: 10.1093/hmg/dds217. Epub 2012 Jun 7.

PMID:
22678062
[PubMed - indexed for MEDLINE]
Free Article
13.

Inducible gene manipulations in brain serotonergic neurons of transgenic rats.

Weber T, Schönig K, Tews B, Bartsch D.

PLoS One. 2011;6(11):e28283. doi: 10.1371/journal.pone.0028283. Epub 2011 Nov 29.

PMID:
22140568
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The power of reversibility regulating gene activities via tetracycline-controlled transcription.

Schönig K, Bujard H, Gossen M.

Methods Enzymol. 2010;477:429-53. doi: 10.1016/S0076-6879(10)77022-1.

PMID:
20699154
[PubMed - indexed for MEDLINE]
15.

Development of a BAC vector for integration-independent and tight regulation of transgenes in rodents via the Tet system.

Schönig K, Kentner D, Gossen M, Baldinger T, Miao J, Welzel K, Vente A, Bartsch D, Bujard H.

Transgenic Res. 2011 Jun;20(3):709-20. doi: 10.1007/s11248-010-9427-0. Epub 2010 Jul 18.

PMID:
20640885
[PubMed - indexed for MEDLINE]
16.

Quantitative analysis of conditional gene inactivation using rationally designed, tetracycline-controlled miRNAs.

Berger SM, Pesold B, Reber S, Schönig K, Berger AJ, Weidenfeld I, Miao J, Berger MR, Gruss OJ, Bartsch D.

Nucleic Acids Res. 2010 Sep;38(17):e168. doi: 10.1093/nar/gkq616. Epub 2010 Jul 17.

PMID:
20639530
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Inducible gene manipulations in serotonergic neurons.

Weber T, Böhm G, Hermann E, Schütz G, Schönig K, Bartsch D.

Front Mol Neurosci. 2009 Nov 6;2:24. doi: 10.3389/neuro.02.024.2009. eCollection 2009.

PMID:
19936315
[PubMed]
Free PMC Article
18.

Construction and application of an inducible system for homogenous expression levels in bulk cell lines.

Yu J, Müller H, Hehn S, Koschmieder S, Schönig K, Berdel WE, Serve H, Müller-Tidow C.

PLoS One. 2009 Jul 30;4(7):e6445. doi: 10.1371/journal.pone.0006445.

PMID:
19649290
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.

Boross P, Breukel C, van Loo PF, van der Kaa J, Claassens JW, Bujard H, Schönig K, Verbeek JS.

Genesis. 2009 Nov;47(11):729-35. doi: 10.1002/dvg.20549.

PMID:
19621440
[PubMed - indexed for MEDLINE]
20.

Inducible expression of coding and inhibitory RNAs from retargetable genomic loci.

Weidenfeld I, Gossen M, Löw R, Kentner D, Berger S, Görlich D, Bartsch D, Bujard H, Schönig K.

Nucleic Acids Res. 2009 Apr;37(7):e50. doi: 10.1093/nar/gkp108. Epub 2009 Mar 5.

PMID:
19264799
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk